Vaccine Manufacture and Supply – Products

At the 2023 Grand Challenges Annual Meeting, Bill Gates, announced new investments to advance access to mRNA research and vaccine manufacturing technology that will support low- and middle-income countries.

New optical technology aims to expedite and enhance the development of viral vectors and gene therapies.

TSG Series Laboratory and Pharmacy Refrigerators are designed and constructed sustainably in a zero-waste facility, offering a cleaner alternative and improved performance at a lower cost.

The Dynabeads™ Streptavidin for in vitro transcription and Dynabeads Carboxylic Acid for RNA purification solutions support scalable GMP-grade synthesis and purification of mRNA for vaccine development and manufacturing.

Vaccizone has selected Exothera S.A. to fast-track process development of its SARS-CoV-2 vaccine for European clinical trials.

Quality Assurance in In Vitro Transcribed RNA Vaccine Development Using Agilent Automated Electrophoresis Instruments

Porvair Sciences high performance, precision manufactured Vyon® porous plastics are perfect support materials for chromatographic resins used in the isolation and purification steps of pharmaceutical drug and vaccine production.

BioNet and BIA Separations, now part of Sartorius, have announced the successful development of an optimized mRNA manufacturing process.

Personalized vaccine strategies minimize deaths and case numbers in a Coronavirus wave of "Variants of Concern" when vaccine supply is limited, a modelling study from Switzerland predicts

FUJIFILM Irvine Scientific, Inc. is celebrating its 50th year of providing cell culture media products and services.